FDA Finds No Misconduct by Care Access in Pfizer’s Lyme Vaccine Trial
Business Wire India Care Access announced today the completion of a for-cause Food and Drug Administration (“FDA”) Good Clinical Practices (“GCP”) inspection related to Care Access’s activities on the Pfizer…